Eloxx Pharmaceuticals Inc

NASDAQ:ELOX   3:59:51 PM EDT
1.78
-0.03 (-1.66%)
Earnings Announcements

Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial And Operating Results And Provides Business Update

Published: 08/16/2021 20:52 GMT
Eloxx Pharmaceuticals Inc (ELOX) - Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update.
Q2 Loss per Share $0.54.
As of June 30, 2021, Had Cash and Cash Equivalents of $56.7 Million.
Expect Cash and Cash Equivalents Will Be Sufficient to Fund Our Operations Into Q1 of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.14

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.